Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) - Total Liabilities

Latest as of March 2026: $3.45 Million USD

Based on the latest financial reports, Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) has total liabilities worth $3.45 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares - Total Liabilities Trend (2021–2025)

This chart illustrates how Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. See Cuprina Holdings (Cayman) Limited Class short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Competitors by Total Liabilities

The table below lists competitors of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares ranked by their total liabilities.

Company Country Total Liabilities
Xstate Resources Ltd
AU:XST
Australia AU$504.11K
CARLSON INV. ZY 13
F:2HB
Germany €1.12 Million
PVW Resources Ltd
AU:PVW
Australia AU$1.02 Million
Butn Ltd
AU:BTN
Australia AU$95.39 Million
Purple Biotech Ltd
TA:PPBT
Israel ILA6.25 Million
Interbud-Lublin SA
WAR:ITB
Poland zł52.17 Million
Wah Fu Education Group Ltd
NASDAQ:WAFU
USA $4.00 Million
Surya Oil & Gas Corp.
NASDAQ:SURY
USA $2.00 Million

Liability Composition Analysis (2021–2025)

This chart breaks down Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CUPR stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.35 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.68 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.41 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (2021–2025)

The table below shows the annual total liabilities of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares from 2021 to 2025.

Year Total Liabilities Change
2025-12-31 $3.45 Million -44.41%
2024-12-31 $6.20 Million +38.41%
2023-12-31 $4.48 Million +39.46%
2022-12-31 $3.21 Million +96.41%
2021-12-31 $1.64 Million --

About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

NASDAQ:CUPR USA Medical Instruments & Supplies
Market Cap
$4.84 Million
Market Cap Rank
#28645 Global
#5813 in USA
Share Price
$5.26
Change (1 day)
-0.19%
52-Week Range
$0.25 - $9.40
All Time High
$9.40
About

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collag… Read more